Qcil secures Shs133 billion loan to build new factory and expand drug output
Stanbic Bank's Head Of Investment Banking - Paula Coetzee, Executive Director Paul Muganwa, Chief Executive Mumba Kalifungwa together with Businessman Emmanuel Katongole during the partnership signing
Quality Chemical Industries Limited (Qcil) is set to build a second manufacturing plant in Luzira, Kampala, after securing a USD 36 million (UGX 133 billion) loan from Stanbic Bank Uganda.
The move will allow the company to scale up its production from 1.4 billion to 2.4 billion tablets annually and venture into new medicine categories, including injectables and tuberculosis treatments.
Qcil, founded in 2005, is the region’s largest producer of World Health Organisation (WHO) pre-qualified HIV/AIDS and malaria medication.
With its products already registered in 31 African countries, the company is positioning itself to meet the continent’s growing healthcare demands through increased local manufacturing.
“This investment enables Qcil to expand capacity while introducing production lines for TB treatment, injectables, and other specialised products,” said Emmanuel Katongole, Qcil’s Chairman and Co-Founder. “We are building the capacity to serve both Uganda and Africa with high-quality, affordable medicines.”
Chief Executive Officer Ajay Kumar Pal described the new factory as a major step towards reducing reliance on imported drugs. “This plant will make us the only manufacturer of TB medicines in the region,” he said. “We’re grateful to Stanbic Bank Uganda for supporting our journey.”
East Africa continues to face severe gaps in local medicine production. Currently, regional pharmaceutical firms supply just 10% of the antiretroviral drugs needed by 5 million people living with HIV, and only 19% of the malaria medication required annually—despite over 54 million malaria cases being reported each year. The region also records more than 600,000 TB cases yearly, yet no local facility currently produces TB medicines.
Stanbic Bank’s Executive Director and Head of Corporate and Investment Banking, Paul Muganwa, noted, “Qcil plays a key role in Uganda’s healthcare sector. We are pleased to back their plan to increase medicine access across the region.”
Mumba Kalifungwa, CEO of Stanbic Bank Uganda, called the deal a “bold and necessary investment.” He added, “This is what it means to finance Uganda’s future—supporting the people and projects that matter most.”

